{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:47:56Z","timestamp":1780688876100,"version":"3.54.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0804"],"award-info":[{"award-number":["W81XWH-20-1-0804"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-25-1-0761"],"award-info":[{"award-number":["HT9425-25-1-0761"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R37NS085318"],"award-info":[{"award-number":["R37NS085318"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Velosano Pilot Award, Cleveland Clinic"},{"name":"Velosano Postdoctoral Award, Cleveland Clinic"},{"DOI":"10.13039\/100012380","name":"CC | Lerner Research Institute, Cleveland Clinic","doi-asserted-by":"publisher","award":["Shared Laboratory Services"],"award-info":[{"award-number":["Shared Laboratory Services"]}],"id":[{"id":"10.13039\/100012380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal cell carcinomas (RCCs) depend on the trimeric sodium-coupled aspartate and glutamate transporter, SLC1A1\/EAAT3; however, pharmacologically targeting SLC1A1 is challenging. Here we determined a cryo-EM structure of human SLC1A1 bound to compound 3e, a recently described SLC1A1-selective bicyclic imidazo[1,2 \u03b1]pyridine-3-amine (BIA) inhibitor with an unclear mechanism of action. 3e binds a membrane-embedded allosteric pocket accessible only in the apo state, when SLC1A1 is unbound to substrate and sodium, and likely prevents sodium and substrate binding. Moreover, by forming a wedge between the trimerization domain and the substrate-binding transport domain, alongside a cholesterol moiety from the lipid bilayer, 3e blocks SLC1A1\u2019s elevator-like movements that support the transport cycle. Mutations in this binding pocket abolish the 3e interaction and counteract 3e\u2019s cytotoxicity in RCC cells, confirming on-target activity and explaining SLC1A1 selectivity. The subsequent design of two new SLC1A1-selective BIA derivatives, PBJ1 and PBJ2, was directed by the SLC1A1-3e structures; both inhibited SLC1A1-dependent aspartate, glutamate, and cysteine metabolism and showed enhanced cytotoxicity.<\/jats:p>","DOI":"10.1038\/s44318-026-00776-2","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:20:51Z","timestamp":1776846051000},"page":"3763-3787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structure-guided optimization of SLC1A1\/EAAT3-selective inhibitors targeting renal cancer metabolism"],"prefix":"10.1038","volume":"45","author":[{"given":"Pooneh","family":"Koochaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-5091","authenticated-orcid":false,"given":"Biao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-9860","authenticated-orcid":false,"given":"Jesse A","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5600-5686","authenticated-orcid":false,"given":"Alexander","family":"Earsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Romigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Goins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleigh","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Days","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6332-1827","authenticated-orcid":false,"given":"Shaun R","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-0851","authenticated-orcid":false,"given":"Olga","family":"Boudker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-188X","authenticated-orcid":false,"given":"Abhishek A","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"776_CR1","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1523\/JNEUROSCI.3396-12.2013","volume":"33","author":"B Abrahamsen","year":"2013","unstructured":"Abrahamsen B, Schneider N, Erichsen MN, Huynh TH, Fahlke C, Bunch L, Jensen AA (2013) Allosteric modulation of an excitatory amino acid transporter: the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain. J Neurosci 33:1068\u20131087","journal-title":"J Neurosci"},{"key":"776_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW et al (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213\u2013221","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"776_CR3","doi-asserted-by":"publisher","first-page":"eaba9854","DOI":"10.1126\/sciadv.aba9854","volume":"6","author":"C Alleva","year":"2020","unstructured":"Alleva C, Kovalev K, Astashkin R, Berndt MI, Baeken C, Balandin T, Gordeliy V, Fahlke C, Machtens JP (2020) Na(+)-dependent gate dynamics and electrostatic attraction ensure substrate coupling in glutamate transporters. Sci Adv 6:eaba9854","journal-title":"Sci Adv"},{"key":"776_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2007.05979.x","volume":"27","author":"K Aoyama","year":"2008","unstructured":"Aoyama K, Matsumura N, Watabe M, Nakaki T (2008) Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. Eur J Neurosci 27:20\u201330","journal-title":"Eur J Neurosci"},{"key":"776_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nn1609","volume":"9","author":"K Aoyama","year":"2006","unstructured":"Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA (2006) Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 9:119\u2013126","journal-title":"Nat Neurosci"},{"key":"776_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1172\/JCI44474","volume":"121","author":"CG Bailey","year":"2011","unstructured":"Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray-Blais C, Vandenberg RJ, Broer S, Rasko JE (2011) Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Investig 121:446\u2013453","journal-title":"J Clin Investig"},{"key":"776_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy K, Wang T, Chen WW, Freinkman E, Abu-Remaileh M, Sabatini DM (2015) An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162:540\u2013551","journal-title":"Cell"},{"key":"776_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature05455","volume":"445","author":"O Boudker","year":"2007","unstructured":"Boudker O, Ryan RM, Yernool D, Shimamoto K, Gouaux E (2007) Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature 445:387\u2013393","journal-title":"Nature"},{"key":"776_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22064","volume":"544","author":"JC Canul-Tec","year":"2017","unstructured":"Canul-Tec JC, Assal R, Cirri E, Legrand P, Brier S, Chamot-Rooke J, Reyes N (2017) Structure and allosteric inhibition of excitatory amino acid transporter 1. Nature 544:446\u2013451","journal-title":"Nature"},{"key":"776_CR10","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108341","volume":"41","author":"JC Canul-Tec","year":"2022","unstructured":"Canul-Tec JC, Kumar A, Dhenin J, Assal R, Legrand P, Rey M, Chamot-Rooke J, Reyes N (2022) The ion-coupling mechanism of human excitatory amino acid transporters. EMBO J 41:e108341","journal-title":"EMBO J"},{"key":"776_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cui L, Lu S, Xu S (2024) Amino acid metabolism in tumor biology and therapy. Cell Death Dis 15:42","journal-title":"Cell Death Dis"},{"key":"776_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature19796","volume":"539","author":"W Chen","year":"2016","unstructured":"Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P et al (2016) Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539:112\u2013117","journal-title":"Nature"},{"key":"776_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature19795","volume":"539","author":"H Cho","year":"2016","unstructured":"Cho H, Du X, Rizzi JP, Liberzon E, Chakraborty AA, Gao W, Carvo I, Signoretti S, Bruick RK, Josey JA et al (2016) On-target efficacy of a HIF-2alpha antagonist in preclinical kidney cancer models. Nature 539:107\u2013111","journal-title":"Nature"},{"key":"776_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1\u2013105","journal-title":"Prog Neurobiol"},{"key":"776_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuint.2016.05.009","volume":"98","author":"NC Danbolt","year":"2016","unstructured":"Danbolt NC, Furness DN, Zhou Y (2016) Neuronal vs glial glutamate uptake: resolving the conundrum. Neurochem Int 98:29\u201345","journal-title":"Neurochem Int"},{"key":"776_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0306-4522(92)90316-T","volume":"51","author":"NC Danbolt","year":"1992","unstructured":"Danbolt NC, Storm-Mathisen J, Kanner BI (1992) An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience 51:295\u2013310","journal-title":"Neuroscience"},{"key":"776_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486\u2013501","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"776_CR18","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1021\/jm1009154","volume":"53","author":"MN Erichsen","year":"2010","unstructured":"Erichsen MN, Huynh TH, Abrahamsen B, Bastlund JF, Bundgaard C, Monrad O, Bekker-Jensen A, Nielsen CW, Frydenvang K, Jensen AA et al (2010) Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101). J Med Chem 53:7180\u20137191","journal-title":"J Med Chem"},{"key":"776_CR19","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1523\/JNEUROSCI.6096-10.2011","volume":"31","author":"PJ Focke","year":"2011","unstructured":"Focke PJ, Moenne-Loccoz P, Larsson HP (2011) Opposite movement of the external gate of a glutamate transporter homolog upon binding cotransported sodium compared with substrate. J Neurosci 31:6255\u20136262","journal-title":"J Neurosci"},{"key":"776_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmet.2013.02.002","volume":"17","author":"PA Gameiro","year":"2013","unstructured":"Gameiro PA, Yang J, Metelo AM, Perez-Carro R, Baker R, Wang Z, Arreola A, Rathmell WK, Olumi A, Lopez-Larrubia P et al (2013) In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab 17:372\u2013385","journal-title":"Cell Metab"},{"key":"776_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez J, Baudrier L, La K, Zhu XG, Fidelin J, Sviderskiy VO, Papagiannakopoulos T, Molina H, Snuderl M, Lewis CA et al (2018) Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat Cell Biol 20:775\u2013781","journal-title":"Nat Cell Biol"},{"key":"776_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, Ferrin TE (2018) UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci 27:14\u201325","journal-title":"Protein Sci"},{"key":"776_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccr.2008.10.016","volume":"14","author":"JD Gordan","year":"2008","unstructured":"Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B et al (2008) HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14:435\u2013446","journal-title":"Cancer Cell"},{"key":"776_CR24","doi-asserted-by":"publisher","first-page":"11913","DOI":"10.1021\/bi050987n","volume":"44","author":"C Grewer","year":"2005","unstructured":"Grewer C, Balani P, Weidenfeller C, Bartusel T, Tao Z, Rauen T (2005) Individual subunits of the glutamate transporter EAAC1 homotrimer function independently of each other. Biochemistry 44:11913\u201311923","journal-title":"Biochemistry"},{"key":"776_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00424-013-1397-7","volume":"466","author":"C Grewer","year":"2014","unstructured":"Grewer C, Gameiro A, Rauen T (2014) SLC1 glutamate transporters. Pflug Arch 466:3\u201324","journal-title":"Pflug Arch"},{"key":"776_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64983-x","volume":"16","author":"T Grubb","year":"2025","unstructured":"Grubb T, Koochaki P, Matar S, Ghandour F, Machaalani M, Saad E, Tang C, Reznik E, Khatun J, Salem C et al (2025) The SLC1A1\/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs. Nat Commun 16:10012","journal-title":"Nat Commun"},{"key":"776_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/0008-5472.CAN-20-0617","volume":"81","author":"W Guo","year":"2021","unstructured":"Guo W, Li K, Sun B, Xu D, Tong L, Yin H, Liao Y, Song H, Wang T, Jing B et al (2021) Dysregulated glutamate transporter SLC1A1 propels cystine uptake via Xc(-) for glutathione synthesis in lung cancer. Cancer Res 81:552\u2013566","journal-title":"Cancer Res"},{"key":"776_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","volume":"34","author":"MA Hediger","year":"2013","unstructured":"Hediger MA, Clemencon B, Burrier RE, Bruford EA (2013) The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Asp Med 34:95\u2013107","journal-title":"Mol Asp Med"},{"key":"776_CR29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00702-003-0049-z","volume":"110","author":"T Himi","year":"2003","unstructured":"Himi T, Ikeda M, Yasuhara T, Nishida M, Morita I (2003) Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons. J Neural Transm 110:1337\u20131348","journal-title":"J Neural Transm"},{"key":"776_CR30","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T (2022) SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res 50:W739\u2013W743","journal-title":"Nucleic Acids Res"},{"key":"776_CR31","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","volume":"385","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ et al (2021) Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med 385:2036\u20132046","journal-title":"N Engl J Med"},{"key":"776_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","volume":"34","author":"Y Kanai","year":"2013","unstructured":"Kanai Y, Clemencon B, Simonin A, Leuenberger M, Lochner M, Weisstanner M, Hediger MA (2013) The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Asp Med 34:108\u2013120","journal-title":"Mol Asp Med"},{"key":"776_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/360467a0","volume":"360","author":"Y Kanai","year":"1992","unstructured":"Kanai Y, Hediger MA (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360:467\u2013471","journal-title":"Nature"},{"key":"776_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32442-6","volume":"13","author":"T Kato","year":"2022","unstructured":"Kato T, Kusakizako T, Jin C, Zhou X, Ohgaki R, Quan L, Xu M, Okuda S, Kobayashi K, Yamashita K et al (2022) Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun 13:4714","journal-title":"Nat Commun"},{"key":"776_CR35","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1523\/JNEUROSCI.0118-07.2007","volume":"27","author":"HP Koch","year":"2007","unstructured":"Koch HP, Brown RL, Larsson HP (2007) The glutamate-activated anion conductance in excitatory amino acid transporters is gated independently by the individual subunits. J Neurosci 27:2943\u20132947","journal-title":"J Neurosci"},{"key":"776_CR36","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","volume":"1","author":"K Kondo","year":"2003","unstructured":"Kondo K, Kim WY, Lechpammer M, Kaelin WG Jr (2003) Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol 1:E83","journal-title":"PLoS Biol"},{"key":"776_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019101468","volume":"38","author":"D Kortzak","year":"2019","unstructured":"Kortzak D, Alleva C, Weyand I, Ewers D, Zimmermann MI, Franzen A, Machtens JP, Fahlke C (2019) Allosteric gate modulation confers K(+) coupling in glutamate transporters. EMBO J 38:e101468","journal-title":"EMBO J"},{"key":"776_CR38","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1523\/JNEUROSCI.4851-06.2007","volume":"27","author":"GP Leary","year":"2007","unstructured":"Leary GP, Stone EF, Holley DC, Kavanaugh MP (2007) The glutamate and chloride permeation pathways are colocalized in individual neuronal glutamate transporter subunits. J Neurosci 27:2938\u20132942","journal-title":"J Neurosci"},{"key":"776_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM (2015) SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov 14:543\u2013560","journal-title":"Nat Rev Drug Discov"},{"key":"776_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","volume":"8","author":"ZN Ling","year":"2023","unstructured":"Ling ZN, Jiang YF, Ru JN, Lu JH, Ding B, Wu J (2023) Amino acid metabolism in health and disease. Signal Transduct Target Ther 8:345","journal-title":"Signal Transduct Target Ther"},{"key":"776_CR41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","volume":"173","author":"TJ Mitchell","year":"2018","unstructured":"Mitchell TJ, Turajlic S, Rowan A, Nicol D, Farmery JHR, O\u2019Brien T, Martincorena I, Tarpey P, Angelopoulos N, Yates LR et al (2018) Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal. Cell 173:611\u2013623.e617","journal-title":"Cell"},{"key":"776_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0169-328X(95)00331-L","volume":"37","author":"TP Palos","year":"1996","unstructured":"Palos TP, Ramachandran B, Boado R, Howard BD (1996) Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter. Mol Brain Res 37:297\u2013303","journal-title":"Mol Brain Res"},{"key":"776_CR43","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1093\/emboj\/16.13.3822","volume":"16","author":"P Peghini","year":"1997","unstructured":"Peghini P, Janzen J, Stoffel W (1997) Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J 16:3822\u20133832","journal-title":"EMBO J"},{"key":"776_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA (2017) cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat methods 14:290\u2013296","journal-title":"Nat methods"},{"key":"776_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38120-5","volume":"14","author":"B Qiu","year":"2023","unstructured":"Qiu B, Boudker O (2023) Symport and antiport mechanisms of human glutamate transporters. Nat Commun 14:2579","journal-title":"Nat Commun"},{"key":"776_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2501627122","volume":"122","author":"B Qiu","year":"2025","unstructured":"Qiu B, Boudker O (2025) Structural basis of excitatory amino acid transporter 3 substrate recognition. Proc Natl Acad Sci USA 122:e2501627122","journal-title":"Proc Natl Acad Sci USA"},{"key":"776_CR47","doi-asserted-by":"publisher","first-page":"eabf5814","DOI":"10.1126\/sciadv.abf5814","volume":"7","author":"B Qiu","year":"2021","unstructured":"Qiu B, Matthies D, Fortea E, Yu Z, Boudker O (2021) Cryo-EM structures of excitatory amino acid transporter 3 visualize coupled substrate, sodium, and proton binding and transport. Sci Adv 7:eabf5814","journal-title":"Sci Adv"},{"key":"776_CR48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature08616","volume":"462","author":"N Reyes","year":"2009","unstructured":"Reyes N, Ginter C, Boudker O (2009) Transport mechanism of a bacterial homologue of glutamate transporters. Nature 462:880\u2013885","journal-title":"Nature"},{"key":"776_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R et al (2018) The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep 23:313\u2013326.e315","journal-title":"Cell Rep"},{"key":"776_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121653119","volume":"119","author":"EA Riederer","year":"2022","unstructured":"Riederer EA, Moenne-Loccoz P, Valiyaveetil FI (2022) Distinct roles of the Na(+) binding sites in the allosteric coupling mechanism of the glutamate transporter homolog, Glt(Ph). Proc Natl Acad Sci USA 119:e2121653119","journal-title":"Proc Natl Acad Sci USA"},{"key":"776_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SH Scheres","year":"2012","unstructured":"Scheres SH (2012) RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180:519\u2013530","journal-title":"J Struct Biol"},{"key":"776_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1124\/mol.53.2.195","volume":"53","author":"K Shimamoto","year":"1998","unstructured":"Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, Nakajima T (1998) DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharm 53:195\u2013201","journal-title":"Mol Pharm"},{"key":"776_CR53","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1124\/mol.65.4.1008","volume":"65","author":"K Shimamoto","year":"2004","unstructured":"Shimamoto K, Sakai R, Takaoka K, Yumoto N, Nakajima T, Amara SG, Shigeri Y (2004) Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol Pharm 65:1008\u20131015","journal-title":"Mol Pharm"},{"key":"776_CR54","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1158\/2159-8290.CD-24-1378","volume":"15","author":"NH Shirole","year":"2025","unstructured":"Shirole NH, Kesar D, Lee Y, Goodale A, Syamala S, Kukreja S, Li R, Qiu X, Yu W, Goldman S et al (2025) Requirement for cyclin D1 underlies cell-autonomous HIF2 dependence in kidney cancer. Cancer Discov 15:1484\u20131504","journal-title":"Cancer Discov"},{"key":"776_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.872335","volume":"13","author":"HJ Sijben","year":"2022","unstructured":"Sijben HJ, Dall\u2019 Acqua L, Liu R, Jarret A, Christodoulaki E, Onstein S, Wolf G, Verburgt SJ, Le Devedec SE, Wiedmer T et al (2022) Impedance-based phenotypic readout of transporter function: a case for glutamate transporters. Front Pharm 13:872335","journal-title":"Front Pharm"},{"key":"776_CR56","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","volume":"162","author":"LB Sullivan","year":"2015","unstructured":"Sullivan LB, Gui DY, Hosios AM, Bush LN, Freinkman E, Vander Heiden MG (2015) Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162:552\u2013563","journal-title":"Cell"},{"key":"776_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","volume":"151","author":"C Suloway","year":"2005","unstructured":"Suloway C, Pulokas J, Fellmann D, Cheng A, Guerra F, Quispe J, Stagg S, Potter CS, Carragher B (2005) Automated molecular microscopy: the new Leginon system. J Struct Biol 151:41\u201360","journal-title":"J Struct Biol"},{"key":"776_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O\u2019Brien T, Lopez JI, Watkins TBK, Nicol D et al (2018) Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal. Cell 173:595\u2013610.e511","journal-title":"Cell"},{"key":"776_CR59","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","volume":"93","author":"RJ Vandenberg","year":"2013","unstructured":"Vandenberg RJ, Ryan RM (2013) Mechanisms of glutamate transport. Physiol Rev 93:1621\u20131657","journal-title":"Physiol Rev"},{"key":"776_CR60","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02283","volume":"3","author":"G Verdon","year":"2014","unstructured":"Verdon G, Oh S, Serio RN, Boudker O (2014) Coupled ion binding and structural transitions along the transport cycle of glutamate transporters. eLife 3:e02283","journal-title":"eLife"},{"key":"776_CR61","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","volume":"76","author":"EM Wallace","year":"2016","unstructured":"Wallace EM, Rizzi JP, Han G, Wehn PM, Cao Z, Du X, Cheng T, Czerwinski RM, Dixon DD, Goggin BS et al (2016) A small-molecule antagonist of HIF2alpha is efficacious in preclinical models of renal cell carcinoma. Cancer Res 76:5491\u20135500","journal-title":"Cancer Res"},{"key":"776_CR62","doi-asserted-by":"publisher","first-page":"e202012577","DOI":"10.1085\/jgp.202012577","volume":"152","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang K, Goyal P, Grewer C (2020) Mechanism and potential sites of potassium interaction with glutamate transporters. J Gen Physiol 152:e202012577","journal-title":"J Gen Physiol"},{"key":"776_CR63","doi-asserted-by":"publisher","first-page":"12180","DOI":"10.1074\/jbc.RA119.009421","volume":"294","author":"J Wang","year":"2019","unstructured":"Wang J, Zielewicz L, Grewer C (2019) A K(+)\/Na(+) co-binding state: Simultaneous versus competitive binding of K(+) and Na(+) to glutamate transporters. J Biol Chem 294:12180\u201312190","journal-title":"J Biol Chem"},{"key":"776_CR64","doi-asserted-by":"publisher","first-page":"e109245","DOI":"10.1371\/journal.pone.0109245","volume":"9","author":"SD Watts","year":"2014","unstructured":"Watts SD, Torres-Salazar D, Divito CB, Amara SG (2014) Cysteine transport through excitatory amino acid transporter 3 (EAAT3). PLoS ONE 9:e109245","journal-title":"PLoS ONE"},{"key":"776_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-025-07453-y","volume":"16","author":"D Wen","year":"2025","unstructured":"Wen D, Li W, Song X, Hu M, Liao Y, Xu D, Deng J, Guo W (2025) NF-kappaB-mediated EAAT3 upregulation in antioxidant defense and ferroptosis sensitivity in lung cancer. Cell Death Dis 16:124","journal-title":"Cell Death Dis"},{"key":"776_CR66","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1021\/acschemneuro.9b00447","volume":"10","author":"P Wu","year":"2019","unstructured":"Wu P, Bjorn-Yoshimoto WE, Staudt M, Jensen AA, Bunch L (2019) Identification and structure-activity relationship study of imidazo[1,2-a]pyridine-3-amines as first selective inhibitors of excitatory amino acid transporter subtype 3 (EAAT3). ACS Chem Neurosci 10:4414\u20134429","journal-title":"ACS Chem Neurosci"},{"key":"776_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103614","volume":"72","author":"J Xiong","year":"2021","unstructured":"Xiong J, Wang N, Zhong HJ, Cui BW, Cheng S, Sun R, Chen JY, Xu PP, Cai G, Wang L et al (2021) SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential. EBioMedicine 72:103614","journal-title":"EBioMedicine"},{"key":"776_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, Wang Y, Guan Q, Qin C, Xiang J et al (2023) HIF-1alpha drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep 42:112945","journal-title":"Cell Rep"},{"key":"776_CR69","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/383634a0","volume":"383","author":"N Zerangue","year":"1996","unstructured":"Zerangue N, Kavanaugh MP (1996) Flux coupling in a neuronal glutamate transporter. Nature 383:634\u2013637","journal-title":"Nature"},{"key":"776_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31031-x","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Chen H, Geng Z, Yu Z, Li H, Dong Y, Zhang H, Huang Z, Jiang J, Zhao Y (2022) Structural basis of ligand binding modes of human EAAT2. Nat Commun 13:3329","journal-title":"Nat Commun"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00776-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-026-00776-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00776-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:31:51Z","timestamp":1780295511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-026-00776-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6,1]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1038\/s44318-026-00776-2","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}